158 related articles for article (PubMed ID: 18179816)
1. IKBKG (nuclear factor-kappa B essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function.
Salt BH; Niemela JE; Pandey R; Hanson EP; Deering RP; Quinones R; Jain A; Orange JS; Gelfand EW
J Allergy Clin Immunol; 2008 Apr; 121(4):976-82. PubMed ID: 18179816
[TBL] [Abstract][Full Text] [Related]
2. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity.
Hanson EP; Monaco-Shawver L; Solt LA; Madge LA; Banerjee PP; May MJ; Orange JS
J Allergy Clin Immunol; 2008 Dec; 122(6):1169-1177.e16. PubMed ID: 18851874
[TBL] [Abstract][Full Text] [Related]
3. Congenital alterations of NEMO glutamic acid 223 result in hypohidrotic ectodermal dysplasia and immunodeficiency with normal serum IgG levels.
Karamchandani-Patel G; Hanson EP; Saltzman R; Kimball CE; Sorensen RU; Orange JS
Ann Allergy Asthma Immunol; 2011 Jul; 107(1):50-6. PubMed ID: 21704885
[TBL] [Abstract][Full Text] [Related]
4. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation.
Orange JS; Jain A; Ballas ZK; Schneider LC; Geha RS; Bonilla FA
J Allergy Clin Immunol; 2004 Apr; 113(4):725-33. PubMed ID: 15100680
[TBL] [Abstract][Full Text] [Related]
5. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.
Orange JS; Levy O; Brodeur SR; Krzewski K; Roy RM; Niemela JE; Fleisher TA; Bonilla FA; Geha RS
J Allergy Clin Immunol; 2004 Sep; 114(3):650-6. PubMed ID: 15356572
[TBL] [Abstract][Full Text] [Related]
6. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
Fusco F; Pescatore A; Conte MI; Mirabelli P; Paciolla M; Esposito E; Lioi MB; Ursini MV
Int Rev Immunol; 2015; 34(6):445-59. PubMed ID: 26269396
[TBL] [Abstract][Full Text] [Related]
7. Immune deficiency caused by impaired expression of nuclear factor-kappaB essential modifier (NEMO) because of a mutation in the 5' untranslated region of the NEMO gene.
Mooster JL; Cancrini C; Simonetti A; Rossi P; Di Matteo G; Romiti ML; Di Cesare S; Notarangelo L; Geha RS; McDonald DR
J Allergy Clin Immunol; 2010 Jul; 126(1):127-32.e7. PubMed ID: 20542322
[TBL] [Abstract][Full Text] [Related]
8. Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation.
Pachlopnik Schmid JM; Junge SA; Hossle JP; Schneider EM; Roosnek E; Seger RA; Gungor T
Pediatrics; 2006 May; 117(5):e1049-56. PubMed ID: 16636116
[TBL] [Abstract][Full Text] [Related]
9. A novel missense mutation in the nuclear factor-κB essential modulator (NEMO) gene resulting in impaired activation of the NF-κB pathway and a unique clinical phenotype presenting as MRSA subdural empyema.
Devora GA; Sun L; Chen Z; van Oers NS; Hanson EP; Orange JS; de la Morena MT
J Clin Immunol; 2010 Nov; 30(6):881-5. PubMed ID: 20652730
[TBL] [Abstract][Full Text] [Related]
10. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia.
Jain A; Ma CA; Liu S; Brown M; Cohen J; Strober W
Nat Immunol; 2001 Mar; 2(3):223-8. PubMed ID: 11224521
[TBL] [Abstract][Full Text] [Related]
11. T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency.
Heller S; Kölsch U; Magg T; Krüger R; Scheuern A; Schneider H; Eichinger A; Wahn V; Unterwalder N; Lorenz M; Schwarz K; Meisel C; Schulz A; Hauck F; von Bernuth H
J Clin Immunol; 2020 Apr; 40(3):421-434. PubMed ID: 31965418
[TBL] [Abstract][Full Text] [Related]
12. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.
Courtois G; Smahi A; Reichenbach J; Döffinger R; Cancrini C; Bonnet M; Puel A; Chable-Bessia C; Yamaoka S; Feinberg J; Dupuis-Girod S; Bodemer C; Livadiotti S; Novelli F; Rossi P; Fischer A; Israël A; Munnich A; Le Deist F; Casanova JL
J Clin Invest; 2003 Oct; 112(7):1108-15. PubMed ID: 14523047
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells from humans with hypomorphic mutations in IKBKG/NEMO have impaired mitogen-activated protein kinase activity.
Ma CA; Wang HY; Temmerman S; Zhao Y; Wu L; Hornung RL; Wara D; Jain A
Hum Mutat; 2011 Mar; 32(3):318-24. PubMed ID: 21309033
[TBL] [Abstract][Full Text] [Related]
14. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling.
Döffinger R; Smahi A; Bessia C; Geissmann F; Feinberg J; Durandy A; Bodemer C; Kenwrick S; Dupuis-Girod S; Blanche S; Wood P; Rabia SH; Headon DJ; Overbeek PA; Le Deist F; Holland SM; Belani K; Kumararatne DS; Fischer A; Shapiro R; Conley ME; Reimund E; Kalhoff H; Abinun M; Munnich A; Israël A; Courtois G; Casanova JL
Nat Genet; 2001 Mar; 27(3):277-85. PubMed ID: 11242109
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation.
Cordier F; Vinolo E; Véron M; Delepierre M; Agou F
J Mol Biol; 2008 Apr; 377(5):1419-32. PubMed ID: 18313693
[TBL] [Abstract][Full Text] [Related]
16. Inherited disorders of human Toll-like receptor signaling: immunological implications.
Ku CL; Yang K; Bustamante J; Puel A; von Bernuth H; Santos OF; Lawrence T; Chang HH; Al-Mousa H; Picard C; Casanova JL
Immunol Rev; 2005 Feb; 203():10-20. PubMed ID: 15661018
[TBL] [Abstract][Full Text] [Related]
17. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations.
Orange JS; Brodeur SR; Jain A; Bonilla FA; Schneider LC; Kretschmer R; Nurko S; Rasmussen WL; Köhler JR; Gellis SE; Ferguson BM; Strominger JL; Zonana J; Ramesh N; Ballas ZK; Geha RS
J Clin Invest; 2002 Jun; 109(11):1501-9. PubMed ID: 12045264
[TBL] [Abstract][Full Text] [Related]
18. Novel hypomorphic mutation in IKBKG impairs NEMO-ubiquitylation causing ectodermal dysplasia, immunodeficiency, incontinentia pigmenti, and immune thrombocytopenic purpura.
Ramírez-Alejo N; Alcántara-Montiel JC; Yamazaki-Nakashimada M; Duran-McKinster C; Valenzuela-León P; Rivas-Larrauri F; Cedillo-Barrón L; Hernández-Rivas R; Santos-Argumedo L
Clin Immunol; 2015 Oct; 160(2):163-71. PubMed ID: 26117626
[TBL] [Abstract][Full Text] [Related]
19. X-linked ectodermal dysplasia with immunodeficiency caused by NEMO mutation: early recognition and diagnosis.
Mancini AJ; Lawley LP; Uzel G
Arch Dermatol; 2008 Mar; 144(3):342-6. PubMed ID: 18347290
[TBL] [Abstract][Full Text] [Related]
20. Functional Evaluation of an IKBKG Variant Suspected to Cause Immunodeficiency Without Ectodermal Dysplasia.
Frans G; van der Werff Ten Bosch J; Moens L; Gijsbers R; Changi-Ashtiani M; Rokni-Zadeh H; Shahrooei M; Wuyts G; Meyts I; Bossuyt X
J Clin Immunol; 2017 Nov; 37(8):801-810. PubMed ID: 28993958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
